V
Ventyx Biosciences D
D
VTYX
2.25000
USD
-0.12
(-4.86%)
مغلق
حجم التداول
28,912
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
160,112,702
العنوان: Ventyx Biosciences
القطاع: Healthcare
الصناعة: Biotechnology
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing apipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.